======= SLC25A4 ======= == Gene Information == * **Official Symbol**: SLC25A4 * **Official Name**: solute carrier family 25 member 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=291|291]] * **UniProt**: [[https://www.uniprot.org/uniprot/P12235|P12235]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SLC25A4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC25A4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/103220|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a member of the mitochondrial carrier subfamily of solute carrier protein genes. The product of this gene functions as a gated pore that translocates ADP from the cytoplasm into the mitochondrial matrix and ATP from the mitochondrial matrix into the cytoplasm. The protein forms a homodimer embedded in the inner mitochondria membrane. Mutations in this gene have been shown to result in autosomal dominant progressive external opthalmoplegia and familial hypertrophic cardiomyopathy. [provided by RefSeq, Jun 2013]. * **UniProt Summary**: Involved in mitochondrial ADP/ATP transport. Catalyzes the exchange of cytoplasmic ADP with mitochondrial ATP across the mitochondrial inner membrane. {ECO:0000269|PubMed:27693233}. |Mito carr| |adenine transmembrane transporter activity| |adenine transport| |ATP:ADP antiporter activity| |ADP transport| |purine nucleobase transport| |integral component of mitochondrial membrane| |nucleobase transport| |negative regulation of necroptotic process| |ATP transport| |negative regulation of programmed necrotic cell death| |adenine nucleotide transport| |negative regulation of necrotic cell death| |purine ribonucleotide transport| |regulation of necroptotic process| |purine nucleotide transport| |mitochondrial genome maintenance| |regulation of programmed necrotic cell death| |nucleotide transport| |regulation of necrotic cell death| |apoptotic mitochondrial changes| |carbohydrate derivative transport| |organophosphate ester transport| |drug transport| |regulation of insulin secretion| |regulation of peptide hormone secretion| |nucleobase-containing compound transport| |regulation of hormone secretion| |mitochondrial inner membrane| |generation of precursor metabolites and energy| |mitochondrion organization| |organic anion transport| |regulation of protein secretion| |regulation of peptide secretion| |regulation of hormone levels| |anion transport| |viral process| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |symbiotic process| |regulation of secretion| |interspecies interaction between organisms| |negative regulation of programmed cell death| |apoptotic process| |negative regulation of cell death| |response to drug| |regulation of protein localization| |programmed cell death| |cell death| |mitochondrion| |transmembrane transport| |ion transport| |integral component of plasma membrane| |regulation of programmed cell death| |regulation of cell death| |nitrogen compound transport| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp532|TIC10 10μM R08 exp532]]|1.7| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13387 * **Expression level (log2 read counts)**: 4.61 {{:chemogenomics:nalm6 dist.png?nolink |}}